European evidence based consensus on the diagnosis and management of Crohn's disease: special situations
- PMID: 16481630
- PMCID: PMC1859996
- DOI: 10.1136/gut.2005.081950c
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations
Abstract
This third section of the European Crohn's and Colitis Organisation (ECCO) Consensus on the management of Crohn's disease concerns postoperative recurrence, fistulating disease, paediatrics, pregnancy, psychosomatics, extraintestinal manifestations, and alternative therapy. The first section on definitions and diagnosis reports on the aims and methods of the consensus, as well as sections on diagnosis, pathology, and classification of Crohn's disease. The second section on current management addresses treatment of active disease, maintenance of medically induced remission, and surgery of Crohn's disease.
Similar articles
-
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.J Crohns Colitis. 2010 Feb;4(1):63-101. doi: 10.1016/j.crohns.2009.09.009. Epub 2009 Dec 21. J Crohns Colitis. 2010. PMID: 21122490 No abstract available.
-
European evidence based consensus on the diagnosis and management of Crohn's disease: current management.Gut. 2006 Mar;55 Suppl 1(Suppl 1):i16-35. doi: 10.1136/gut.2005.081950b. Gut. 2006. PMID: 16481629 Free PMC article.
-
European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ['Exit Strategies'] in Inflammatory Bowel Disease.J Crohns Colitis. 2018 Jan 5;12(1):17-31. doi: 10.1093/ecco-jcc/jjx101. J Crohns Colitis. 2018. PMID: 28981623 Review.
-
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management.J Crohns Colitis. 2017 Jan;11(1):3-25. doi: 10.1093/ecco-jcc/jjw168. Epub 2016 Sep 22. J Crohns Colitis. 2017. PMID: 27660341
-
Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.Dan Med Bull. 2011 Dec;58(12):B4360. Dan Med Bull. 2011. PMID: 22142578
Cited by
-
Surgical strategies in paediatric inflammatory bowel disease.World J Gastroenterol. 2015 May 28;21(20):6101-16. doi: 10.3748/wjg.v21.i20.6101. World J Gastroenterol. 2015. PMID: 26034347 Free PMC article. Review.
-
Impact of postoperative infliximab maintenance therapy on preventing the surgical recurrence of Crohn's disease: a single-center paired case-control study.Surg Today. 2014 Feb;44(2):291-6. doi: 10.1007/s00595-013-0538-0. Epub 2013 Mar 6. Surg Today. 2014. PMID: 23463537
-
Crohn's disease: a review of current treatment with a focus on biologics.Drugs. 2007;67(17):2511-37. doi: 10.2165/00003495-200767170-00005. Drugs. 2007. PMID: 18034589 Review.
-
Postoperative complications have little influence on long-term quality of life in Crohn's patients.J Gastrointest Surg. 2008 Mar;12(3):569-76. doi: 10.1007/s11605-007-0412-8. Epub 2007 Nov 28. J Gastrointest Surg. 2008. PMID: 18043989
-
Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn's disease.Dig Dis Sci. 2007 Feb;52(2):385-9. doi: 10.1007/s10620-006-9549-7. Epub 2007 Jan 9. Dig Dis Sci. 2007. PMID: 17211699 Clinical Trial.
References
-
- Caprilli R, Andreoli A, Capurso L, Gruppo Italiano per lo Studio del Colon e del Retto (GISC) et al Oral mesalazine (5‐aminosalicylic acid; Asacol) for the prevention of post‐operative recurrence of CD. Aliment Pharmacol Ther 1994835–43. - PubMed
-
- Whelan G, Farmer R G, Fazio V W, Goormastic M. Recurrence after surgery in Crohn's disease. Gastroenterology 1985881826–1833. - PubMed
-
- Tytgat G N J, Mulder C J J, Brummelkamp W H. Endoscopic lesions in Crohn's disease early after ileocecal resection. Endoscopy 198820260–262. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical